News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
383,277 Results
Type
Article (26045)
Company Profile (62)
Press Release (357170)
Multimedia
Podcasts (27)
Webinars (7)
Section
Business (104570)
Career Advice (453)
Deals (16943)
Drug Delivery (51)
Drug Development (47634)
Employer Resources (47)
FDA (12274)
Job Trends (8479)
News (186357)
Policy (19448)
Tag
Academia (1754)
Accelerated approval (3)
Adcomms (8)
Allergies (74)
Alliances (26830)
ALS (59)
Alzheimer's disease (819)
Antibody-drug conjugate (ADC) (57)
Approvals (12338)
Artificial intelligence (178)
Autoimmune disease (10)
Automation (4)
Bankruptcy (142)
Best Places to Work (6913)
BIOSECURE Act (5)
Biosimilars (36)
Biotechnology (43)
Bladder cancer (60)
Brain cancer (18)
Breast cancer (203)
Cancer (1481)
Cardiovascular disease (123)
Career advice (410)
Career pathing (13)
CAR-T (73)
Cell therapy (209)
Cervical cancer (14)
Clinical research (40603)
Collaboration (461)
Compensation (139)
Complete response letters (9)
COVID-19 (1495)
CRISPR (16)
C-suite (149)
Cystic fibrosis (43)
Data (1606)
Decentralized trials (2)
Denatured (19)
Depression (31)
Diabetes (178)
Diagnostics (3603)
Digital health (12)
Diversity (5)
Diversity, equity & inclusion (13)
Drug discovery (53)
Drug pricing (58)
Drug shortages (21)
Duchenne muscular dystrophy (57)
Earnings (37205)
Editorial (22)
Employer branding (6)
Employer resources (44)
Events (52057)
Executive appointments (459)
FDA (13335)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (3)
Funding (419)
Gene editing (42)
Generative AI (11)
Gene therapy (136)
GLP-1 (408)
Government (3045)
Grass and pollen (3)
Guidances (97)
Healthcare (12218)
Huntington's disease (10)
IgA nephropathy (16)
Immunology and inflammation (46)
Indications (19)
Infectious disease (1567)
Inflammatory bowel disease (82)
Inflation Reduction Act (4)
Influenza (27)
Intellectual property (51)
Interviews (40)
IPO (7081)
IRA (19)
Job creations (1856)
Job search strategy (379)
Kidney cancer (7)
Labor market (13)
Layoffs (176)
Leadership (6)
Legal (3635)
Liver cancer (57)
Lung cancer (234)
Lymphoma (103)
Machine learning (4)
Management (17)
Manufacturing (111)
MASH (57)
Medical device (12915)
Medtech (12918)
Mergers & acquisitions (10168)
Metabolic disorders (449)
Multiple sclerosis (56)
NASH (11)
Neurodegenerative disease (51)
Neuropsychiatric disorders (9)
Neuroscience (1167)
NextGen: Class of 2025 (3948)
Non-profit (2830)
Now hiring (17)
Obesity (221)
Opinion (76)
Ovarian cancer (56)
Pain (66)
Pancreatic cancer (56)
Parkinson's disease (91)
Partnered (13)
Patents (119)
Patient recruitment (84)
Peanut (37)
People (34860)
Pharmaceutical (18)
Pharmacy benefit managers (12)
Phase I (11632)
Phase II (17585)
Phase III (14437)
Pipeline (783)
Policy (62)
Postmarket research (1668)
Preclinical (3635)
Press Release (18)
Prostate cancer (79)
Psychedelics (17)
Radiopharmaceuticals (162)
Rare diseases (188)
Real estate (2860)
Recruiting (16)
Regulatory (14255)
Reports (17)
Research institute (1611)
Resumes & cover letters (48)
Rett syndrome (2)
RNA editing (2)
RSV (20)
Schizophrenia (54)
Series A (70)
Series B (51)
Service/supplier (3)
Sickle cell disease (23)
Special edition (5)
Spinal muscular atrophy (103)
Sponsored (13)
Startups (2133)
Stomach cancer (8)
Supply chain (38)
Tariffs (17)
The Weekly (8)
Vaccines (364)
Venture capitalists (13)
Weight loss (142)
Women's health (19)
Worklife (4)
Date
Today (92)
Last 7 days (505)
Last 30 days (1639)
Last 365 days (18498)
2025 (6548)
2024 (19964)
2023 (22819)
2022 (30754)
2021 (33077)
2020 (32293)
2019 (28534)
2018 (21885)
2017 (18947)
2016 (18148)
2015 (21223)
2014 (16056)
2013 (13266)
2012 (14375)
2011 (14638)
2010 (13191)
Location
Africa (357)
Alabama (18)
Alaska (3)
Arizona (119)
Arkansas (10)
Asia (24664)
Australia (3904)
California (3200)
Canada (1257)
China (383)
Colorado (167)
Connecticut (177)
Delaware (124)
Europe (48191)
Florida (572)
Georgia (135)
Idaho (33)
Illinois (364)
India (14)
Indiana (232)
Iowa (3)
Japan (125)
Kansas (74)
Kentucky (12)
Louisiana (9)
Maine (27)
Maryland (650)
Massachusetts (2233)
Michigan (110)
Minnesota (281)
Mississippi (2)
Missouri (52)
Montana (18)
Nebraska (18)
Nevada (37)
New Hampshire (60)
New Jersey (1163)
New Mexico (10)
New York (999)
North Carolina (567)
North Dakota (4)
Northern California (1407)
Ohio (135)
Oklahoma (3)
Oregon (23)
Pennsylvania (858)
Puerto Rico (7)
Rhode Island (25)
South America (522)
South Carolina (23)
Southern California (1232)
Tennessee (79)
Texas (562)
United States (13289)
Utah (117)
Virginia (82)
Washington D.C. (42)
Washington State (233)
West Virginia (3)
Wisconsin (43)
383,277 Results for "reshape medical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
IN PARTNERSHIP WITH DIA
Economic Challenges, Strategic Investments: Reshaping the Women’s Health Landscape
In this episode presented by DIA, BioSpace’s head of insights Lori Ellis discusses how collaboration and investment shape the the future of women’s health with Martin Hodosi, partner at Kearney and Melissa Laitner, director of strategic initiatives at the National Academy of Medicine.
April 24, 2025
·
1 min read
·
Lori Ellis
MASH
7 Late-Stage MASH Candidates That Could Reshape the Market
Akero Therapeutics, 89bio, Boston Pharmaceuticals and more are working to bring novel treatment options for metabolic dysfunction-associated steatohepatitis to a market that could reach $16 billion by 2033.
April 7, 2025
·
6 min read
·
Ben Hargreaves
Press Releases
Roquette Reshapes the Pharmaceutical Coating Landscape with an Innovative and High-Performance Platform
February 11, 2025
·
4 min read
Press Releases
ORYZON to Reshape Its Board of Directors at the Upcoming Shareholders’ Meeting
January 27, 2025
·
9 min read
Leadership
Leadership Lab: Take a Cue From Athletes by Working With an Executive Coach
Executive coaches can help executives take their game to the next level in four key ways, from improving their self-awareness to reshaping their thinking.
February 19, 2025
·
6 min read
·
Michael Pietrack
Opinion
Opinion: A Small Pharma Mindset Can Reshape Big Pharma and Improve Patient Care
An appreciation for practicality, independent thinking and patient care can help disrupt the bureaucracy of Big Pharma.
September 12, 2024
·
3 min read
·
Jill Marie Drury
Press Releases
Tenon Medical(R) Receives Approval for Notice of Allowance from the European Patent Office
March 11, 2025
·
2 min read
Press Releases
Tenon Medical(R) Announces FDA Clearance of Catamaran(R) SI Joint Fusion System for New Indication to Augment Spinal Fusion
March 24, 2025
·
2 min read
Deals
Royalty Financing Serves as Lifeline for Some Biopharma Companies in Uncertain Market
As traditional fundraising methods falter for smaller firms, the rise of royalty deals is reshaping how companies access capital, offering an alternative that bypasses equity dilution and debt.
October 2, 2024
·
5 min read
·
Ben Hargreaves
Press Releases
FIRST PATIENT ENROLLED IN AKURA MEDICAL’S US PIVOTAL TRIAL FOR PULMONARY EMBOLISM
February 4, 2025
·
3 min read
1 of 38,328
Next
